Katherine Belfield1, Roger Bayston1, Nadzieja Hajduk1, Georgia Levell1, John P Birchall2,3,4, Matija Daniel2,3,4. 1. Biomaterials-Related Infection Group, Department of Orthopaedics, Trauma and Sports Medicine, School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, UK. 2. NIHR Nottingham Hearing Biomedical Research Unit, Nottingham University Hospitals, Ropewalk House, Nottingham, UK. 3. Otology and Hearing Group, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, UK. 4. Otorhinolaryngology, Nottingham University Hospitals, Queen's Medical Centre, Nottingham, UK.
Abstract
Objectives: To evaluate potential anti-biofilm agents for their ability to enhance the activity of antibiotics for local treatment of localized biofilm infections. Methods: Staphylococcus aureus and Pseudomonas aeruginosa in vitro biofilm models were developed. The putative antibiotic enhancers N-acetylcysteine, acetylsalicylic acid, sodium salicylate, recombinant human deoxyribonuclease I, dispersin B, hydrogen peroxide and Johnson's Baby Shampoo (JBS) were tested for their anti-biofilm activity alone and their ability to enhance the activity of antibiotics for 7 or 14 days, against 5 day old biofilms. The antibiotic enhancers were paired with rifampicin and clindamycin against S. aureus and gentamicin and ciprofloxacin against P. aeruginosa. Isolates from biofilms that were not eradicated were tested for antibiotic resistance. Results: Antibiotic levels 10× MIC and 100× MIC significantly reduced biofilm, but did not consistently eradicate it. Antibiotics at 100× MIC with 10% JBS for 14 days was the only treatment to eradicate both staphylococcal and pseudomonal biofilms. Recombinant human deoxyribonuclease I significantly reduced staphylococcal biofilm. Emergence of resistance of surviving isolates was minimal and was often associated with the small colony variant phenotype. Conclusions: JBS enhanced the activity of antibiotics and several other promising anti-biofilm agents were identified. Antibiotics with 10% JBS eradicated biofilms produced by both organisms. Such combinations might be useful in local treatment of localized biofilm infections.
Objectives: To evaluate potential anti-biofilm agents for their ability to enhance the activity of antibiotics for local treatment of localized biofilm infections. Methods: Staphylococcus aureus and Pseudomonas aeruginosa in vitro biofilm models were developed. The putative antibiotic enhancers N-acetylcysteine, acetylsalicylic acid, sodium salicylate, recombinant human deoxyribonuclease I, dispersin B, hydrogen peroxide and Johnson's Baby Shampoo (JBS) were tested for their anti-biofilm activity alone and their ability to enhance the activity of antibiotics for 7 or 14 days, against 5 day old biofilms. The antibiotic enhancers were paired with rifampicin and clindamycin against S. aureus and gentamicin and ciprofloxacin against P. aeruginosa. Isolates from biofilms that were not eradicated were tested for antibiotic resistance. Results: Antibiotic levels 10× MIC and 100× MIC significantly reduced biofilm, but did not consistently eradicate it. Antibiotics at 100× MIC with 10% JBS for 14 days was the only treatment to eradicate both staphylococcal and pseudomonal biofilms. Recombinant human deoxyribonuclease I significantly reduced staphylococcal biofilm. Emergence of resistance of surviving isolates was minimal and was often associated with the small colony variant phenotype. Conclusions: JBS enhanced the activity of antibiotics and several other promising anti-biofilm agents were identified. Antibiotics with 10% JBS eradicated biofilms produced by both organisms. Such combinations might be useful in local treatment of localized biofilm infections.
Authors: Steven L Percival; Dieter Mayer; Robert S Kirsner; Greg Schultz; Dot Weir; Sashwati Roy; Afsaneh Alavi; Marco Romanelli Journal: Int Wound J Date: 2019-03-18 Impact factor: 3.315
Authors: Adam Benedict Turner; Erik Gerner; Rininta Firdaus; Maite Echeverz; Maria Werthén; Peter Thomsen; Sofia Almqvist; Margarita Trobos Journal: Front Microbiol Date: 2022-08-01 Impact factor: 6.064
Authors: Felice Valzano; Selene Rebecca Boncompagni; Maria Micieli; Tiziana Di Maggio; Vincenzo Di Pilato; Lorenzo Colombini; Francesco Santoro; Gianni Pozzi; Gian Maria Rossolini; Lucia Pallecchi Journal: Microbiol Spectr Date: 2022-06-23